> top > docs > PubMed:10212389 > annotations

PubMed:10212389 JSONTXT

Annnotations TAB JSON ListView MergeView

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 319-359 cell_line denotes human promyelocytic leukemia HL-60 cells
T2 413-435 protein denotes retinoic acid receptor
T3 437-440 protein denotes RAR

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-47 Sentence denotes Dicarba-closo-dodecaboranes as a pharmacophore.
S2 48-94 Sentence denotes Retinoidal antagonists and potential agonists.
S3 95-222 Sentence denotes Synthesis and biological evaluation of the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids are described.
S4 223-360 Sentence denotes Their retinoidal activity were examined in terms of the differentiation-inducing ability toward human promyelocytic leukemia HL-60 cells.
S5 361-560 Sentence denotes High retinoidal activity (agonist or antagonist for retinoic acid receptor (RAR) requires a carboxylic acid moiety and an appropriate hydrophobic group located at a suitable position on the molecule.
S6 561-714 Sentence denotes The 4-carboranyl-substituted compounds (7, 11) showed antagonistic activity but no agonistic activity even in the presence of the potent synergist HX630.
S7 715-847 Sentence denotes On the other hand, the 3-carboranyl-substituted compounds (8, 12) showed potential agonistic activity, but no antagonistic activity.
S8 848-960 Sentence denotes The results indicates that carboranes are applicable as the hydrophobic moiety of biologically active molecules.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 0-27 NP denotes Dicarba-closo-dodecaboranes
C2 134-207 NP denotes the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids
C3 223-228 NP denotes Their
C4 875-885 NP denotes carboranes
R1 C3 C2 coref-pron Their,the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids
R2 C4 C1 coref-ident carboranes,Dicarba-closo-dodecaboranes

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-27 other_organic_compound denotes Dicarba-closo-dodecaboranes
T2 33-46 other_name denotes pharmacophore
T3 48-70 other_organic_compound denotes Retinoidal antagonists
T4 75-93 other_organic_compound denotes potential agonists
T5 144-170 other_organic_compound denotes dicarba-closo-dodecaborane
T6 172-181 other_organic_compound denotes carborane
T7 198-207 other_organic_compound denotes retinoids
T8 319-359 cell_line denotes human promyelocytic leukemia HL-60 cells
T9 413-435 protein_family_or_group denotes retinoic acid receptor
T10 437-440 protein_family_or_group denotes RAR
T11 453-475 other_organic_compound denotes carboxylic acid moiety
T12 483-512 other_organic_compound denotes appropriate hydrophobic group
T13 565-599 other_organic_compound denotes 4-carboranyl-substituted compounds
T14 601-602 other_organic_compound denotes 7
T15 604-606 other_organic_compound denotes 11
T16 691-707 other_name denotes potent synergist
T17 708-713 other_organic_compound denotes HX630
T18 738-772 other_organic_compound denotes 3-carboranyl-substituted compounds
T19 774-775 other_organic_compound denotes 8
T20 777-779 other_organic_compound denotes 12
T21 798-816 other_name denotes agonistic activity
T22 825-846 other_name denotes antagonistic activity
T23 908-926 other_organic_compound denotes hydrophobic moiety

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 339-347 HP_0001909 denotes leukemia